Replies to post #12292 on ALR Technologies SG Ltd (ALRTF)

[TheLastOneSitting]

How could somebody spend so much time complaining yet so little time researching the company they are complaining about? It is truly astounding.

There are only two companies selling CGMs (since Medtronic is basically out of the picture), Abbott and Dexcom. Dexcom is 4x the cost of Libre and priced out of the animal market and Libre will not sell to veterinarians or make an animal CGM. Literally one phone call to a veterinarians or one google search would tell you that information in minutes.

So please tell me what "big player" is going to spend a million dollars creating software for the next year and then when they do that please tell me how they are going to sell a CGM? Find me one manufacturer they could partner with anywhere in the world.

Just looking at the USA alone, there are 1 million diabetic animals. With no competition. ALRT will have 100% of the market as the ONLY pet cgm. If the animals use it 3 times a year that is 3,000,000 times $x amount of profit. If they even make $10 that is $30,000,000 and I assume they will make a lot more then that.

If you don't believe the animal market will make money you're a fool for staying invested in a company you think will fail. And if you do think it will make money why are you crying?

[BuzzLite]

23 x 750k = about the same as ALRT. And developing software for consumer product companies is way easier route than seeking pharma and FDA approvals. Seeking partnerships takes time as well. I’m ok where we are now. Let’s go ALRT.

[BuzzLite]

23 x 750k = about the same as ALRT. And developing software for consumer product companies is way easier route than seeking pharma and FDA approvals. Seeking partnerships takes time as well. I’m ok where we are now. Let’s go ALRT.